Acute myeloid leukemia (AML) is an aggressive cancer known for drug resistance and relapse. In an effort to uncover new treatment strategies, researchers have discovered that a cell surface molecule known as CD98 promotes AML.
Antibody breaks leukemia's hold, providing new therapeutic approach
Science Daily - 28 Oct 2016 17:51
Acute myeloid leukemia (AML) is an aggressive cancer known for drug resistance and relapse. In an effort to uncover new treatment strategies, researchers have discovered that a cell surface molecule known as CD98 promotes AML.
Share this Article
Recommended